Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOcado Regulatory News (OCDO)

Share Price Information for Ocado (OCDO)

Share Price is delayed by 15 minutes
Get Live Data
203.20    -1.80 (-0.88%)
Bid:
203.00
Ask:
203.40
Spread: 0.40 (0.197%)
Market Cap: £1.69b
OCDO Live PriceLast checked at - London Stock Exchange

Intraday Ocado Share Chart

Update on Financing Transaction

14 Jun 2017 15:52

RNS Number : 1093I
Ocado Group PLC
14 June 2017
 

OCADO GROUP PLC

 

14 June 2017

Successful Upsizing and Pricing of £250 million Senior Secured Notes due 2024

Further to the announcement of 12 June 2017, Ocado Group plc ("Ocado") today announces that it has successfully priced an offering of £250,000,000 Senior Secured Notes due 2024 at a coupon of 4% ("the Offering") and an issue price of 100%. Due to strong demand the Offering was upsized from the originally anticipated size of £200,000,000. The Offering is expected to close on 19 June 2017. On closing the Offering, Ocado expects to complete the amendment and extension of its Revolving Credit Facility with final commitments of £100,000,000 which has been reduced proportionately to the upsizing of the Offering (together with the Offering, the "Financing Transactions").

 

These Financing Transactions will extend the maturity profile of Ocado's debt and diversify our sources of funding as well as increase the overall level of funding available to Ocado to grow the business. As a result of its continued strong trading, increased scale and profitability, Ocado has benefitted from the historically low financing costs in the public debt markets to put in place longer maturity financing on attractive terms. The proceeds of the Offering will support the continued growth of Ocado's UK retail capacity, and further improvements to our proprietary platform, and will also be used to repay existing debt under Ocado's Revolving Credit Facility and retire certain finance lease obligations.

 

Contacts

Duncan Tatton-Brown, Chief Financial Officer, on 01707 228 000

David Hardiman-Evans, Head of IR & Corporate Finance, on 01707 228 000

Michelle Clarke or Susanna Voyle, Tulchan Communications, on 020 7353 4200

 

Financial Calendar

Ocado's financial reporting calendar for the remainder of the year will be a Half Year Results Statement on 5 July 2017, a Q3 Trading Statement on 19 September 2017 and a Q4 Trading Statement on 14 December 2017. 

 

Important Information

NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA.

Certain statements made in this announcement are forward-looking statements. Such statements are based on current expectations and assumptions and are subject to a number of risks and uncertainties that could cause actual events or results to differ materially from any expected future events or results expressed or implied in these forward-looking statements. Persons receiving this announcement should not place undue reliance on forward-looking statements. Unless otherwise required by applicable law, regulation or accounting standard, Ocado does not undertake to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

These materials are not an offer of securities for sale in the United States. Any securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States. Any securities sold in the United States will be sold only to qualified institutional buyers (as defined in Rule 144A under the Securities Act) pursuant to Rule 144A. Any decision to invest in the notes offered in the Offering must be made solely based on the information in the Offering Memorandum.

This announcement is for informational purposes only and is directed only at persons who are: (a) persons in member states of the European Economic Area (the "EEA") who are qualified investors (as defined in EU Prospectus Directive 2003/71/EC (as amended, including by EU Directive 2010/73/EU to the extent implemented in the relevant member state)); (b) persons in the United Kingdom who are qualified investors and who are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) persons falling within Article 49(2) (a) to (d) of the Order ("high net worth companies, unincorporated associations, etc."); or (iii) persons to whom an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any senior secured notes may otherwise be lawfully communicated or cause to be communicated (all such persons in (a) and (b) together being referred to as "relevant persons"). This announcement must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

In connection with the offer of the above securities, the Stabilising Managers may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there can be no assurance that the Stabilising Managers will take any stabilisation action, and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBSGDLISBBGRS
Date   Source Headline
27th Jul 20213:14 pmRNSBlock listing Interim Review
21st Jul 20211:45 pmRNSDirector/PDMR Shareholding
19th Jul 20215:34 pmRNSDirector/PDMR Shareholding
16th Jul 202112:34 pmRNSDirector/PDMR Shareholding
6th Jul 20217:02 amRNSAnnouncement of partnership with Alcampo
6th Jul 20217:00 amRNSHalf-year Report
1st Jul 20215:06 pmRNSTotal Voting Rights
1st Jul 20214:17 pmRNSDirector/PDMR Shareholding
15th Jun 20215:31 pmRNSDirector/PDMR Shareholding
1st Jun 202112:26 pmRNSTotal Voting Rights
18th May 202110:09 amRNSDirector/PDMR Shareholding
13th May 20216:14 pmRNSResult of AGM
13th May 20217:00 amRNSHolding(s) in Company
11th May 202112:44 pmRNSDirector/PDMR Shareholding
7th May 20216:26 pmRNSDirector/PDMR Shareholding
4th May 20215:42 pmRNSTotal Voting Rights
28th Apr 20214:44 pmRNSDirector/PDMR Shareholding
23rd Apr 20215:22 pmRNSDirector/PDMR Shareholding
16th Apr 20213:39 pmRNSDirector/PDMR Shareholding
16th Apr 20217:00 amRNSOcado Invests in Oxbotica
13th Apr 20219:04 amRNSChange of Director's Details
1st Apr 202111:17 amRNSTotal Voting Rights
25th Mar 20218:00 amRNSDirector/PDMR Shareholding
25th Mar 20217:00 amRNSDirector/PDMR Shareholding
22nd Mar 20216:27 pmRNSDirector/PDMR Shareholding
22nd Mar 20216:21 pmRNSDirector/PDMR Shareholding
22nd Mar 202112:34 pmRNSDirector/PDMR Shareholding
22nd Mar 202110:06 amRNSDirector/PDMR Shareholding
18th Mar 20219:25 amRNSDirector/PDMR Shareholding
18th Mar 20217:00 amRNSTrading Statement
9th Mar 20214:24 pmRNSAdditional Listing
1st Mar 20213:59 pmRNSTotal Voting Rights
25th Feb 20217:00 amRNSHolding(s) in Company
17th Feb 20216:15 pmRNSDirector/PDMR Shareholding
16th Feb 20213:24 pmRNSNotice of AGM
15th Feb 20217:15 amRNSDirectorate Appointment Date
12th Feb 20212:54 pmRNSDirector/PDMR Shareholding
10th Feb 20214:05 pmRNSDirector/PDMR Shareholding
9th Feb 202112:00 pmRNSAnnual Financial Report
9th Feb 20217:00 amRNSFinal Results
2nd Feb 20218:57 amRNSDirectorate Change
1st Feb 20212:20 pmRNSTotal Voting Rights
27th Jan 20219:05 amRNSBlock listing Interim Review
5th Jan 20215:17 pmRNSTotal Voting Rights
21st Dec 20203:31 pmRNSCompletion of Acquisition
18th Dec 20206:25 pmRNSDirectorate Change
16th Dec 20205:43 pmRNSDirector/PDMR Shareholding
15th Dec 20207:00 amRNSCompletion of Acquisition
10th Dec 20207:00 amRNSTrading Statement
1st Dec 202012:53 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.